BioCentury
ARTICLE | Company News

EyeTech eyes IOMED for drug delivery

October 24, 2000 7:00 AM UTC

EyeTech (New York, N.Y.) and IOX entered a collaboration to test EyeTech's EYE001 anti-angiogenic agent delivered by IOX's non-invasive OcuPhor transscleral drug delivery system to prevent age-related...